However, studies in patient-derived xenograft and murine AML models showed that the combination of tyrosine kinase inhibitor AC220 with MS023 increased apoptosis of FLT3-ITD + AML cells as compared to AC220 treatment alone [71]. Here, FLT3 is linked to acute myeloid leukemia.